Results
1 -
6 of
6
(Click
here to explore results)
- Design, synthesis and biological evaluation of novel 5-hydroxy-2-methyl-4H-pyran-4-one derivatives as antiglioma agents. Yi-Bin Li, Wen Hou, Hui Lin, Ping-Hua Sun, Jing Lin, Wei-Min Chen
, Med. Chem. Commun.
, 2018
, 9
, 471
- Asperspiropene A, a novel fungal metabolite as an inhibitor of cancer-associated mutant isocitrate dehydrogenase 1. Yan He, Mengzhu Zheng, Qin Li, Zhengxi Hu, Hucheng Zhu, Junjun Liu, Jianping Wang, Yongbo Xue, Hua Li, Yonghui Zhang
, Org. Chem. Front.
, 2017
, 4
, 1137
- Identification of a novel selective inhibitor of mutant isocitrate dehydrogenase 1 at allosteric site by docking-based virtual screening. Fangxia Zou, Stefan Pusch, Jessica Eisel, Tianfang Ma, Qihua Zhu, Dawei Deng, Yueqing Gu, Yungen Xu, Andreas von Deimling, Xiaoming Zha
, RSC Adv.
, 2016
, 6
, 96735
- Will the chemical probes please stand up?. Ctibor Škuta, Christopher Southan, Petr Bartůněk
, RSC Med. Chem.
, 2021
, 12
, 1428
- Nanomedicine facilitated cell signaling blockade: difficulties and strategies to overcome glioblastoma. Mohammad Habeeb, Hariharan Thirumalai Vengateswaran, Huay Woon You, Kundharu Saddhono, Kiran Balasaheb Aher, Girija Balasaheb Bhavar
, J. Mater. Chem. B
, 2024
, 12
, 1677
- Nitrile-containing pharmaceuticals: target, mechanism of action, and their SAR studies. Xi Wang, Yuanxun Wang, Xuemin Li, Zhenyang Yu, Chun Song, Yunfei Du
, RSC Med. Chem.
, 2021
, 12
, 1650